One of the major scientific crusades in oncology has been to identify and validate biomarkers associated with recurrent breast cancer. [iStock / royaltystockphoto]

Case Study: Breast Cancer YAPI (Yet Another Prognostic Indicator) Revisited: ASCO Recommendations

Using biomarker assays guide decision-making processes and standardize clinical approaches for women with early-stage invasive breast cancer
Source: NIH

Essential Mouse Genes Are Related to Many Human Disease Genes

Mutant traits have, for the first time, been identified in mice for 52 human disease genes.
Source: PeopleImages/Getty Images

Genes Responsible for Extreme Form of Morning Sickness Identified

UCLA researchers say two genes involved in placental development and appetite regulation are associated with hyperemesis gravidarum (HG)
Source: Stanislaw Pytel/Getty Images

100,000 Genomes Project Hits its Mark

Launched in 2012 by then Prime Minister David Cameron, the project is the centerpiece of NHS's Genomic Medicine Service unveiled in October
Source: David Marchal/Getty Images

Caris Inks Pancreatic Cancer Diagnostics Deal with Threshold Pharmaceuticals

Caris will use its ADAPT system to develop a diagnostic intended to classify potential outcomes for Threshold's drug candidate evofosfamide.
kirstypargeter/Getty Images

Next-Gen Sequencing for Diagnosing Brain Infections

New pilot study successfully used advanced DNA sequencing methods as a diagnostic tool to uncover latent brain infections.
A researcher at Stanford University holding a tube of blood after centrifugation. The pale yellow liquid on top is blood plasma containing cell-free DNA. Cell-free DNA in easy-to-obtain samples such as blood or urine is revolutionizing precision medicine approaches in many fields of medicine including oncology

Cell-Free DNA Prospecting Starts to Pan Out

With all the buzz surrounding liquid biopsies, people might think circulating cell-free DNA (cfDNA) is a new discovery. Not so, according to Iwijn De...

FDA Authorizes Marketing for 23andMe Bloom Syndrome Carrier Status Test

The FDA has granted 23andMe authority for marketing a direct-to-consumer genetic test, nearly a year and a half after forcing the company to stop...
Source:  iLexx/Getty Images

Curetis Spins Out Antibiotic Resistance Test Company Ares Genetics

The new company will leverage the genetic antibiotic resistance and susceptibility database (GEAR) assets acquired last fall from Siemens.

Discovery of Functional Serum Biomarkers

Lung cancer is one of the most common malignancies and the leading cause of cancer-related fatality. In the United States alone, more than 210,000...
Scroll Up